Effect of insulin-induced hypoglycaemia on the central nervous system: Evidence from experimental studies

Journal of Neuroendocrinology

Volumn 26, Issue 3, 2014, Pages 123-150

  Jensen, V F H ^a,b   Bogh I B ^b   Lykkesfeldt, J ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NOVO NORDISK A S   (Denmark)

Author keywords

Binding proteins; Glucose transporters; Insulin; Membrane; Receptors

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCOSE; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 2; GLUCOSE TRANSPORTER 3; GLUCOSE TRANSPORTER 4; GLYCOGEN; INSULIN; INSULIN RECEPTOR; SODIUM GLUCOSE COTRANSPORTER;

AGE; AMYGDALOID NUCLEUS; APPETITE; ARCUATE NUCLEUS; BRAIN LEVEL; BRAIN METABOLISM; CALORIC RESTRICTION; CENTRAL NERVOUS SYSTEM; CHOLINERGIC NERVE CELL; COMA; CONCENTRATION (PARAMETERS); DOWN REGULATION; ELECTROENCEPHALOGRAM; ENDOPLASMIC RETICULUM; EXTRACELLULAR SPACE; GLUCOSE BLOOD LEVEL; GLUCOSE BRAIN LEVEL; GLUCOSE TRANSPORT; GLYCOGEN MUSCLE LEVEL; HIPPOCAMPUS; HORMONE RESPONSE; HUMAN; HYPERINSULINEMIA; HYPOGLYCEMIA; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; IN VITRO STUDY; INFERIOR COLLICULUS; INSULIN BLOOD LEVEL; INSULIN BRAIN LEVEL; INSULIN INDUCED HYPOGLYCAEMIA; INSULIN RELEASE; INSULIN SYNTHESIS; INTESTINE EPITHELIUM CELL; LATERAL HYPOTHALAMUS; LIPID BRAIN LEVEL; MOTONEURON NUCLEUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SEIZURE; SMALL INTESTINE; VULNERABLE POPULATION; WHITE MATTER; ZONA INCERTA; ANIMAL; BIOSYNTHESIS; BRAIN; CHEMICALLY INDUCED; HOMEOSTASIS; LEWIS RAT; METABOLISM; PATHOPHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; WISTAR RAT;

ANIMALS; BRAIN; GLUCOSE; HOMEOSTASIS; HYPOGLYCEMIA; INSULIN; RATS; RATS, INBRED LEW; RATS, SPRAGUE-DAWLEY; RATS, WISTAR;

EID: 84897845695     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/jne.12133     Document Type: Review

References (340)

1. The DCCT Research Group. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med 1991; 4: 450-459.
2. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 14: 977-986.
3. Miller C, Phillips L, Ziemer D, Gallina D, Cook C, El-Kebbi I. Hypoglycemia in patients with type 2 diabetes mellitus. Arch Intern Med 2001; 13: 1653-1659.
4. Widom B, Simonson D. Intermittent hypoglycemia impairs glucose counterregulation. Diabetes 1992; 12: 1597-1602.
5. Cryer P. Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM - a vicious cycle. Diabetes 1992; 3: 255-260.
6. Cryer PE. Mechanisms of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med 2013; 4: 362-372.
7. Thorens B. Brain glucose sensing and neural regulation of insulin and glucagon secretion. Diabetes Obes Metab 2011; S1: 82-88.
8. Watts AG, Donovan CM. Sweet talk in the brain: glucosensing, neural networks, and hypoglycemic counterregulation. Front Neuroendocrinol 2010; 1: 32-43.
9. Hevener A, Bergman R, Donovan C. Novel glucosensor for hypoglycemic detection localized to the portal vein. Diabetes 1997; 9: 1521-1525.
10. Koyama Y, Coker R, Stone E, Lacy D, Jabbour K, Williams P, Wasserman D. Evidence that carotid bodies play an important role in glucoregulation in vivo. Diabetes 2000; 9: 1434-1442.
11. Liu M, Seino S, Kirchgessner A. Identification and characterization of glucoresponsive neurons in the enteric nervous system. J Neurosci 1999; 23: 10305-10317.
12. Borg M, Sherwin R, Borg W, Tamborlane W, Shulman G. Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats. J Clin Invest 1997; 2: 361-365.
13. Ritter R, Slusser P, Stone S. Glucoreceptors controlling feeding and blood-glucose - location in the hindbrain. Science 1981; 4506: 451-453.
14. Childs B, Clark N, Cox D, Cryer P, Davis S, Dinardo M, Kahn R, Kovatchev B, Shamoon H, American Diabetes Assoc Workgroup. Defining and reporting hypoglycemia in diabetes - a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 2005; 5: 1245-1249.
15. Daly M, Vale C, Walker M, Littlefield A, Alberti K, Mathers J. Acute effects on insulin sensitivity and diurnal metabolic profiles of a high-sucrose compared with a high-starch diet. Am J Clin Nutr 1998; 6: 1186-1196.
16. Scheepers A, Joost H, Schurmann A. The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function. J Parenter Enteral Nutr 2004; 5: 364-371.
17. Wood I, Trayhurn P. Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins. Br J Nutr 2003; 1: 3-9.
18. Devaskar S, Mueckler M. The mammalian glucose transporters. Pediatr Res 1992; 1: 1-13.
19. Gould G, Holman G. The glucose-transporter family - structure, function and tissue-specific expression. Biochem J 1993; 295: 329-341.
20. Duelli R, Kuschinsky W. Brain glucose transporters: relationship to local energy demand. News Physiol Sci 2001; 2: 71-76.
21. Li B, Xi X, Roane DS, Ryan DH, Martin RJ. Distribution of glucokinase, glucose transporter GLUT2, sulfonylurea receptor-1, glucagon-like peptide-1 receptor and neuropeptide Y messenger RNAs in rat brain by quantitative real time RT-PCR. Brain Res Mol Brain Res 2003; 1-2: 139-142.
22. Leloup C, Arluison M, Kassis N, Lepetit N, Cartier N, Ferre P, Penicaud L. Discrete brain areas express the insulin-responsive glucose transporter GLUT4. Mol Brain Res 1996; 1: 45-53.
23. Reagan L, Rosell D, Alves S, Hoskin E, McCall A, Charron M, McEwen B. GLUT8 glucose transporter is localized to excitatory and inhibitory neurons in the rat hippocampus. Brain Res 2002; 1-2: 129-134.
24. Rand EB, Depaoli AM, Davidson NO, Bell GI, Burant CF. Sequence, tissue distribution, and functional characterization of the rat fructose transporter GLUT5. Am J Physiol 1993; 6: G1169-G1176.
25. McEwen B, Reagan L. Glucose transporter expression in the central nervous system: relationship to synaptic function. Eur J Pharmacol 2004; 1-3: 13-24.
26. Gerhart D, Levasseur R, Broderius M, Drewes L. Glucose transporter localization in brain using light and electron immunocytochemistry. J Neurosci Res 1989; 4: 464-472.
27. McCall A, VanBueren A, Nipper V, MoholtSiebert M, Downes H, Lessov N. Forebrain ischemia increases GLUT1 protein in brain microvessels and parenchyma. J Cereb Blood Flow Metab 1996; 1: 69-76.
28. Nagamatsu S, Sawa H, Kamada K, Nakamichi Y, Yoshimoto K, Hoshino T. Neuron-specific glucose-transporter (NSGT) - CNS distribution of GLUT3 Rat glucose-transporter (RGT3) in rat central neurons. FEBS Lett 1993; 3: 289-295.
29. Vannucci S, Maher F, Simpson I. Glucose transporter proteins in brain: delivery of glucose to neurons and glia. Glia 1997; 1: 2-21.
30. Mueckler M, Weng W, Kruse M. Glutamine-161 of Glut1 glucose-transporter is critical for transport activity and exofacial ligand-binding. J Biol Chem 1994; 32: 20533-20538.
31. Simpson IA, Dwyer D, Malide D, Moley KH, Travis A, Vannucci SJ. The facilitative glucose transporter GLUT3: 20 years of distinction. Am J Physiol Endocrinol Metab 2008; 2: E242-E253.
32. Yu AS, Hirayama BA, Timbol G, Liu J, Basarah E, Kepe V, Satyamurthy N, Huang S, Wright EM, Barrio JR. Functional expression of SGLTs in rat brain. Am J Physiol Cell Physiol 2010; 6: C1277-C1284.
33. Yu AS, Hirayama BA, Timbol G, Liu J, Diez-Sampedro A, Kepe V, Satyamurthy N, Huang S, Wright EM, Barrio JR. Regional distribution of SGLT activity in rat brain in vivo. Am J Physiol Cell Physiol 2013; 3: C240-C247.
34. +-d-glucose cotransporter SGLT1 in rat organs with an improved antibody. Am J Physiol Cell Physiol 2008; 2: C475-C489.
35. +/glucose cotransporter - reevaluation of function and distribution of expression. J Biol Chem 1994; 16: 12032-12039.
36. +-d-glucose cotransporter SGLT1 in neurons. J Neurochem 1997; 1: 84-94.
37. Nishizaki T, Kammesheidt A, Sumikawa K, Asada T, Okada Y. A sodium-dependent and energy-dependent glucose-transporter with similarities to SGLT1-2 is expressed in bovine cortical vessels. Neurosci Res 1995; 1: 13-22.
38. +-d-glucose cotransporter SGLT1 in the blood-brain barrier. Histochem Cell Biol 2004; 3: 201-207.
39. +-glucose cotransporters. Am J Physiol Renal Physiol 2001; 1: F10-F18.
40. Kipp H, Khoursandi S, Scharlau D, Kinne R. More than apical: distribution of SGLT1 in Caco-2 cells. Am J Physiol Cell Physiol 2003; 4: C737-C749.
41. Ikari A, Nakano M, Kawano K, Suketa Y. Up-regulation of sodium-dependent glucose transporter by interaction with heat shock protein 70. J Biol Chem 2002; 36: 33338-33343.
42. +-dependent glucose transport during differentiation of an intestinal epithelial cell clone is regulated by protein kinase C. J Biol Chem 1995; 21: 12536-12541.
43. Abi-Saab W, Maggs D, Jones T, Jacob R, Srihari V, Thompson J, Kerr D, Leone P, Krystal J, Spencer D, During M, Sherwin R. Striking differences in glucose and lactate levels between brain extracellular fluid and plasma in conscious human subjects: effects of hyperglycemia and hypoglycemia. J Cereb Blood Flow Metab 2002; 3: 271-279.
44. Dunn-Meynell AA, Sanders NM, Compton D, Becker TC, Eiki J, Zhang BB, Levin BE. Relationship among brain and blood glucose levels and spontaneous and glucoprivic feeding. J Neurosci 2009; 21: 7015-7022.
45. de Vries M, Arseneau L, Lawson M, Beverly J. Extracellular glucose in rat ventromedial hypothalamus during acute and recurrent hypoglycemia. Diabetes 2003; 11: 2767-2773.
46. Barnes MB, Lawson MA, Beverly JL. Rate of fall in blood glucose and recurrent hypoglycemia affect glucose dynamics and noradrenergic activation in the ventromedial hypothalamus. Am J Physiol Regul Integr Comp Physiol 2011; 6: R1815-R1820.
47. Langemann H, Alessandri B, Mendelowitsch A, Feuerstein T, Landolt H, Gratzl O. Extracellular levels of glucose and lactate measured by quantitative microdialysis in the human brain. Neurol Res 2001; 5: 531-536.
48. Ono T, Steffens AB, Sasaki K. Influence of peripheral and intracerebroventricular glucose and insulin infusions on peripheral and cerebrospinal-fluid glucose and insulin levels. Physiol Behav 1983; 2: 301-306.
49. Steffens A, Scheurink A, Porte D, Woods S. Penetration of peripheral glucose and insulin into cerebrospinal-fluid in rats. Am J Physiol 1988; 2: R200-R204.
50. Smith F, Dailey M, Merritt H, Carroll M, Thomas G. The equilibrium between cerebrospinal fluid and blood plasma I. The composition of the human cerebrospinal fluid and blood plasma. Arch Neurol Psychiatr 1931; 6: 1271-1289.
51. Owen O, Reichard G, Boden G, Shuman C. Comparative measurements of glucose, beta-hydroxybutyrate, acetoacetate, and insulin in blood and cerebrospinal fluid during starvation. Metabolism 1974; 1: 7-14.
52. Cohn D, Levinson A, McCarthy F. Physiological variations in the glucose ratio of blood and cerebrospinal fluid. Am J Physiol 1933; 3: 613-619.
53. Lamers K, Doesburg W, Gabreels F, Romsom A, Lemmens W, Wevers R, Renier W. CSF concentration and CSF-blood ratio of fuel related components in children after prolonged fasting. Clin Chim Acta 1987; 2: 135-145.
54. Marks V. True glucose content of lumbar and ventricular cerebrospinal fluid. J Clin Pathol 1960; 1: 82-84.
55. Silver IA, Erecinska M. Extracellular glucose concentration in mammalian brain - continuous monitoring of changes during increased neuronal activity and upon limitation in oxygen supply in normoglycemic, hypoglycemic, and hyperglycemic animals. J Neurosci 1994; 8: 5068-5076.
56. Langlet F, Levin BE, Luquet S, Mazzone M, Messina A, Dunn-Meynell AA, Balland E, Lacombe A, Mazur D, Carmeliet P, Bouret SG, Prevot V, Dehouck B. Tanycytic VEGF-A boosts blood-hypothalamus barrier plasticity and access of metabolic signals to the arcuate nucleus in response to fasting. Cell Metab 2013; 4: 607-617.
57. Lee D, Chung M, Lee J, Kang D, Paek Y. Changes of glucose transporters in the cerebral adaptation to hypoglycemia. Diabetes Res Clin Pract 2000; 1: 15-23.
58. Kumagai A, Kang Y, Boado R, Pardridge W. Up-regulation of blood-brain barrier GLUT1 glucose transporter protein and messenger RNA in experimental chronic hypoglycemia. Diabetes 1995; 12: 1399-1404.
59. Uehara Y, Nipper V, McCall A. Chronic insulin hypoglycemia induces GLUT-3 protein in rat brain neurons. Am J Physiol Endocrinol Metab 1997; 4: E716-E719.
60. Simpson I, Appel N, Hokari M, Oki J, Holman G, Maher F, Koehler-Stec E, Vannucci S, Smith Q. Blood-brain barrier glucose transporter: effects of hypo- and hyperglycemia revisited. J Neurochem 1999; 1: 238-247.
61. Duelli R, Staudt R, Duembgen L, Kuschinsky W. Increase in glucose transporter densities of Glut3 and decrease of glucose utilization in rat brain after one week of hypoglycemia. Brain Res 1999; 1-2: 254-262.
62. Boado R, Pardridge W. Glucose deprivation causes posttranscriptional enhancement of brain capillary endothelial glucose transporter gene expression via GLUT1 messenger RNA stabilization. J Neurochem 1993; 6: 2290-2296.
63. Walker P, Donovan J, Vanness B, Fellows R, Pessin J. Glucose-dependent regulation of glucose transport activity, protein, and messenger RNA in primary cultures of rat brain glial cells. J Biol Chem 1988; 30: 15594-15601.
64. Nagamatsu S, Sawa H, Inoue N, Nakamichi Y, Takeshima H, Hoshino T. Gene expression of GLUT3 glucose transporter regulated by glucose in vivo in mouse brain and in vitro in neuronal cell cultures from rat embryos. Biochem J 1994; 1: 125-131.
65. Moran A, Turner R, Handler J. Hexose regulation of sodium-hexose transport in LLC-PK1 epithelia - the nature of the signal. J Membr Biol 1984; 1: 59-65.
66. Moran A, Turner R, Handler J. Regulation of sodium-coupled glucose transport by glucose in a cultured epithelium. J Biol Chem 1983; 24: 5087-5090.
67. Ohta T, Isselbacher K, Rhoads D. Regulation of glucose transporters in LLC-PK1 cells - effects of d-glucose and monosaccharides. Mol Cell Biol 1990; 12: 6491-6499.
68. Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD, Sakurada O, Shinohara M. The [C-14]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 1977; 28: 897-916.
69. Suda S, Shinohara M, Miyaoka M, Lucignani G, Kennedy C, Sokoloff L. The lumped constant of the deoxyglucose method in hypoglycemia - effects of moderate hypoglycemia on local cerebral glucose utilization in the rat. J Cereb Blood Flow Metab 1990; 4: 499-509.
70. Ghajar J, Plum F, Duffy T. Cerebral oxidative metabolism and blood flow during acute hypoglycemia and recovery in unanesthetized rats. J Neurochem 1982; 2: 397-409.
71. Pelligrino D, Segil L, Albrecht R. Brain glucose utilization and transport and cortical function in chronic vs acute hypoglycemia. Am J Physiol 1990; 5: E729-E735.
72. Abdulrahman A, Siesjo B. Local cerebral glucose consumption during insulin-induced hypoglycemia, and in the recovery period following glucose administration. Acta Physiol Scand 1980; 2: 149-159.
73. Bryan R, Keefer K, Macneill C. Regional cerebral glucose utilization during insulin-induced hypoglycemia in unanesthetized rats. J Neurochem 1986; 6: 1904-1911.
74. McCall A, Fixman L, Fleming N, Tornheim K, Chick W, Ruderman N. Chronic hypoglycemia increases brain glucose transport. Am J Physiol 1986; 4: E442-E447.
75. Choi I, Tkac I, Ugurbil K, Gruetter R. Noninvasive measurements of [1-C-13]glycogen concentrations and metabolism in rat brain in vivo. J Neurochem 1999; 3: 1300-1308.
76. Choi I, Seaquist E, Gruetter R. Effect of hypoglycemia on brain glycogen metabolism in vivo. J Neurosci Res 2003; 1: 25-32.
77. Herzog RI, Chan O, Yu S, Dziura J, Mcnay EC, Sherwin RS. Effect of acute and recurrent hypoglycemia on changes in brain glycogen concentration. Endocrinology 2008; 4: 1499-1504.
78. 13C MR brain glycogen quantification at 9.4 and 14.1 T. Magn Reson Med 2012; 6: 1523-1527.
79. Oz G, Seaquist ER, Kumar A, Criego AB, Benedict LE, Rao JP, Henry P, Van De Moortele P, Gruetter R. Human brain glycogen content and metabolism: implications on its role in brain energy metabolism. Am J Physiol Endocrinol Metab 2007; 3: E946-E951.
80. Brown A. Brain glycogen re-awakened. J Neurochem 2004; 3: 537-552.
81. Obel LF, Muller MS, Walls AB, Sickmann HM, Bak LK, Waagepetersen HS, Schousboe A. Brain glycogen - new perspectives on its metabolic function and regulation at the subcellular level. Front Neuroenergetics 2012; 3: 1-15.
82. Gruetter R. Glycogen: the forgotten cerebral energy store. J Neurosci Res 2003; 2: 179-183.
83. Brown AM, Ransom BR. Astrocyte glycogen and brain energy metabolism. Glia 2007; 12: 1263-1271.
84. Canada SE, Weaver SA, Sharpe SN, Pederson BA. Brain glycogen supercompensation in the mouse after recovery from insulin-induced hypoglycemia. J Neurosci Res 2011; 4: 585-591.
85. Oz G, Kumar A, Rao JP, Kodl CT, Chow L, Eberly LE, Seaquist ER. Human brain glycogen metabolism during and after hypoglycemia. Diabetes 2009; 9: 1978-1985.
86. Hutchins D, Rogers K. Physiological and drug-induced changes in glycogen content of mouse brain. Br J Pharmacol 1970; 1: 9-25.
87. Matsui T, Soya S, Okamoto M, Ichitani Y, Kawanaka K, Soya H. Brain glycogen decreases during prolonged exercise. J Physiol (Lond) 2011; 13: 3383-3393.
88. Matsui T, Ishikawa T, Ito H, Okamoto M, Inoue K, Lee M, Fujikawa T, Ichitani Y, Kawanaka K, Soya H. Brain glycogen supercompensation following exhaustive exercise. J Physiol (Lond) 2012; 3: 607-616.
89. Suh SW, Bergher JP, Anderson CM, Treadway JL, Fosgerau K, Swanson RA. Astrocyte glycogen sustains neuronal activity during hypoglycemia: studies with the glycogen phosphorylase inhibitor CP-316, 819 ([R-R*, S*]-5-chloro-N-[2-hydroxy-3(methoxymethylamino)-3-oxo-1-(phenylme thyl)propyl]-1H-indole2-carboxamide). J Pharmacol Exp Ther 2007; 1: 45-50.
90. Lei H, Gruetter R. Effect of chronic hypoglycaemia on glucose concentration and glycogen content in rat brain: a localized C-13 NMR study. J Neurochem 2006; 1: 260-268.
91. Wang R, Liu X, Hentges S, Dunn-Meynell A, Levin B, Wang W, Routh V. The regulation of glucose-excited neurons in the hypothalamic arcuate nucleus by glucose and feeding relevant peptides. Diabetes 2004; 8: 1959-1965.
92. Silver I, Erecinska M. Glucose-induced intracellular ion changes in sugar-sensitive hypothalamic neurons. J Neurophysiol 1998; 4: 1733-1745.
93. Karnani MM, Szabo G, Erdelyi F, Burdakov D. Lateral hypothalamic GAD65 neurons are spontaneously firing and distinct from orexin- and melanin-concentrating hormone neurons. J Physiol (Lond) 2013; 4: 933-953.
94. Marston OJ, Hurst P, Evans ML, Burdakov DI, Heisler LK. Neuropeptide Y cells represent a distinct glucose-sensing population in the lateral hypothalamus. Endocrinology 2011; 11: 4046-4052.
95. + channel in rat brain. Brain Res 1998; 1-2: 41-54.
96. Melnick IV, Price CJ, Colmers WF. Glucosensing in parvocellular neurons of the rat hypothalamic paraventricular nucleus. Eur J Neurosci 2011; 2: 272-282.
97. Adachi A, Shimizu N, Oomura Y, Kobashi M. Convergence of hepato-portal glucose-sensitive afferent signals to glucose-sensitive units within the nucleus of the solitary tract. Neurosci Lett 1984; 2: 215-218.
98. Dallaporta M, Himmi T, Perrin J, Orsini J. Solitary tract nucleus sensitivity to moderate changes in glucose level. NeuroReport 1999; 12: 2657-2660.
99. Mizuno Y, Oomura Y. Glucose responding neurons in the nucleus tractus solitarius of the rat - invitro study. Brain Res 1984; 1-2: 109-116.
100. Leloup C, Arluison M, Lepetit N, Cartier N, Marfaingjallat P, Ferre P, Penicaud L. Glucose transporter 2 (GLUT-2) - expression in specific brain nuclei. Brain Res 1994; 1-2: 221-226.
101. Levin BE, Kang L, Sanders NM, Dunn-Meynell AA. Role of neuronal glucosensing in the regulation of energy homeostasis. Diabetes 2006; S2: S122-S130.
102. Levin B, Dunn-Meynell A, Routh V. CNS Sensing and Regulation of Peripheral Glucose Levels. Waltham, MA: International Review of Neurobiology: Academic Press Inc., 2002: 219-258.
103. Yang X, Kow L, Pfaff D, Mobbs C. Metabolic pathways that mediate inhibition of hypothalamic neurons by glucose. Diabetes 2004; 1: 67-73.
104. Yang X, Kow L, Funabashi T, Mobbs C. Hypothalamic glucose sensor - similarities to and differences from pancreatic beta-cell mechanisms. Diabetes 1999; 9: 1763-1772.
105. Levin BE, Routh VH, Kang L, Sanders NM, Dunn-Meynell AA. Perspectives in diabetes - neuronal glucosensing what do we know after 50 years? Diabetes 2004; 10: 2521-2528.
106. Penicaud L, Leloup C, Lorsignol A, Alquier T, Guillod E. Brain glucose sensing mechanism and glucose homeostasis. Curr Opin Clin Nutr Metab Care 2002; 5: 539-543.
107. Diez-Sampedro A, Hirayama B, Osswald C, Gorboulev V, Baumgarten K, Volk C, Wright E, Koepsell H. A glucose sensor hiding in a family of transporters. Proc Natl Acad Sci USA 2003; 20: 11753-11758.
108. Gribble F, Williams L, Simpson A, Reimann F. A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line. Diabetes 2003; 5: 1147-1154.
109. O'Malley D, Reimann F, Simpson AK, Gribble FM. Sodium-coupled glucose cotransporters contribute to hypothalamic glucose sensing. Diabetes 2006; 12: 3381-3386.
110. Kang L, Routh V, Kuzhikandathil E, Gaspers L, Levin B. Physiological and molecular characteristics of rat hypothalamic ventromedial nucleus glucosensing neurons. Diabetes 2004; 3: 549-559.
111. Tsujii S, Bray G. Effects of glucose, 2-deoxyglucose, phlorizin, and insulin on food intake of lean and fatty rats. Am J Physiol 1990; 3: E476-E481.
112. Glick Z, Mayer J. Hyperphagia caused by cerebral ventricular infusion of phloridzin. Nature 1968; 5161: 1374.
113. Dunn-Meynell A, Routh V, Kang L, Gaspers L, Levin B. Glucokinase is the likely mediator of glucosensing in both glucose-excited and glucose-inhibited central neurons. Diabetes 2002; 7: 2056-2065.
114. Watson R, Pessin J. Subcellular compartmentalization and trafficking of the insulin-responsive glucose transporter, GLUT4. Exp Cell Res 2001; 1: 75-83.
115. Leloup C, Orosco M, Serradas P, Nicolaidis S, Penicaud L. Specific inhibition of GLUT2 in arcuate nucleus by antisense oligonucleotides suppresses nervous control of insulin secretion. Mol Brain Res 1998; 2: 275-280.
116. Wan H, Hulsey M, Martin R. Intracerebroventricular administration of antisense oligodeoxynucleotide against GLUT2 glucose transporter mRNA reduces food intake, body weight change and glucoprivic feeding response in rats. J Nutr 1998; 2: 287-291.
117. Reno C, Puente E, Daphna-Iken D, Kahn B, Fisher S. Brain-specific glucose transporter 4 knockout mice display decreased brain glucose uptake and hepatic insulin resistance (Abstract). Diabetes 2010; 61(Suppl 1): A59.
118. Puente EC, Daphna-Iken D, Bree AJ, Suzuki Y, Georgopoulos I, Kahn BB, Fisher SJ. Impaired counterregulatory response to hypoglycemia and impaired glucose tolerance in brain glucose transporter 4 (GLUT4) knockout mice. Diabetes 2009; A13-A14.
119. Canabal DD, Song Z, Potian JG, Beuve A, McArdle JJ, Routh VH. Glucose, insulin, and leptin signaling pathways modulate nitric oxide synthesis in glucose-inhibited neurons in the ventromedial hypothalamus. Am J Physiol Regul Integr Comp Physiol 2007; 4: R1418-R1428.
120. Fioramonti X, Marsollier N, Song Z, Fakira KA, Patel RM, Brown S, Duparc T, Pica-Mendez A, Sanders NM, Knauf C, Valet P, McCrimmon RJ, Beuve A, Magnan C, Routh VH. Ventromedial hypothalamic nitric oxide production is necessary for hypoglycemia detection and counterregulation. Diabetes 2010; 2: 519-528.
121. Murphy BA, Fakira KA, Song Z, Beuve A, Routh VH. AMP-activated protein kinase and nitric oxide regulate the glucose sensitivity of ventromedial hypothalamic glucose-inhibited neurons. Am J Physiol Cell Physiol 2009; 3: C750-C758.
122. Karnani M, Burdakov D. Multiple hypothalamic circuits sense and regulate glucose levels. Am J Physiol Regul Integr Comp Physiol 2011; 1: R47-R55.
123. + channels stimulated by glucose: a new energy-sensing pathway. Pflugers Arch 2007; 1: 19-27.
124. + channels mediate inhibition of orexin neurons by glucose. Neuron 2006; 5: 711-722.
125. Leloup C, Arluison M, Lepetit N, Cartier N, Marfaingjallat P, Ferre P, Penicaud L. Glucose transporter 2 (GLUT-2) - expression in specific brain nuclei. Brain Res 1994; 638: 221-226.
126. Young J, McKenzie J. GLUT2 immunoreactivity in Gomori-positive astrocytes of the hypothalamus. J Histochem Cytochem 2004; 11: 1519-1524.
127. Arluison M, Quignon M, Nguyen P, Thorens B, Leloup C, Penicaud L. Distribution and anatomical localization of the glucose transporter 2 (GLUT2) in the adult rat brain - an immunohistochemical study. J Chem Neuroanat 2004; 3: 117-136.
128. Garcia M, Millan C, Balmaceda-Aguilera C, Castro T, Pastor P, Montecinos H, Reinicke K, Zuniga F, Vera J, Onate S, Nualart F. Hypothalamic ependymal-glial cells express the glucose transporter GLUT2, a protein involved in glucose sensing. J Neurochem 2003; 3: 709-724.
129. Ngarmukos C, Baur E, Kumagai A. Co-localization of GLUT1 and GLUT4 in the blood-brain barrier of the rat ventromedial hypothalamus. Brain Res 2001; 1: 1-8.
130. Marty N, Dallaporta M, Foretz M, Emery M, Tarussio D, Bady I, Binnert C, Beermann F, Thorens B. Regulation of glucagon secretion by glucose transporter type 2 (glut2) and astrocytedependent glucose sensors. J Clin Invest 2005; 12: 3545-3553.
131. Guillod-Maximin E, Lorsignol A, Alquier T, Penicaud L. Acute intracarotid glucose injection towards the brain induces specific c-fos activation in hypothalamic nuclei: involvement of astrocytes in cerebral glucose-sensing in rats. J Neuroendocrinol 2004; 5: 464-471.
132. Young J, Baker J, Montes M. The brain response to 2-deoxy glucose is blocked by a glial drug. Pharmacol Biochem Behav 2000; 2: 233-239.
133. Sanders N, Dunn-Meynell A, Levin B. Third ventricular alloxan reversibly impairs glucose counterregulatory responses. Diabetes 2004; 5: 1230-1236.
134. Brawer J, Stein R, Small L, Cisse S, Schipper H. Composition of Gomori-positive inclusions in astrocytes of the hypothalamic arcuate nucleus. Anat Rec 1994; 3: 407-415.
135. Wang X, Manganaro F, Schipper H. A cellular stress model for the sequestration of redox-active glial iron in the aging and degenerating nervous system. J Neurochem 1995; 4: 1868-1877.
136. Schipper H, Mydlarski M, Wang X. Cysteamine gliopathy in situ - a cellular stress model for the biogenesis of astrocytic inclusions. J Neuropathol Exp Neurol 1993; 4: 399-410.
137. Watson RT, Pessin JE. GLUT4 translocation: the last 200 nanometers. Cell Signal 2007; 11: 2209-2217.
138. El Messari S, Leloup C, Quignon M, Brisorgueil MJ, Penicaud L, Arluison M. Immunocytochemical localization of the insulin-responsive glucose transporter 4 (Glut4) in the rat central nervous system. J Comp Neurol 1998; 4: 492-512.
139. Apelt J, Mehlhorn G, Schliebs R. Insulin-sensitive GLUT4 glucose transporters are colocalized with GLUT3-expressing cells and demonstrate a chemically distinct neuron-specific localization in rat brain. J Neurosci Res 1999; 5: 693-705.
140. Benomar Y, Naour N, Aubourg A, Bailleux V, Gertler A, Djiane J, Guerre-Millo M, Taouis M. Insulin and leptin induce Glut4 plasma membrane translocation and glucose uptake in a human neuronal cell line by a phosphatidylinositol 3-kinase-dependent mechanism. Endocrinology 2006; 5: 2550-2556.
141. + channels in hypothalamic neurons of lean, but not obese rats. Nat Neurosci 2000; 8: 757-758.
142. Cotero VE, Routh VH. Insulin blunts the response of glucose-excited neurons in the ventrolateral-ventromedial hypothalamic nucleus to decreased glucose. Am J Physiol Endocrinol Metab 2009; 2: E560-E561.
143. Cryer P. Hierarchy of physiological responses to hypoglycemia: relevance to clinical hypoglycemia in type I (insulin dependent) diabetes mellitus. Horm Metab Res 1997; 3: 92-96.
144. Gerich J, Cryer P, Rizza R. Hormonal mechanisms in acute glucose counterregulation - the relative roles of glucagon, epinephrine, norepinephrine, growth hormone, and cortisol. Metabolism 1980; 11: 1164-1175.
145. De Feo P, Perriello G, Decosmo S, Ventura MM, Campbell PJ, Brunetti P, Gerich JE, Bolli GB. Comparison of glucose counterregulation during short-term and prolonged hypoglycemia in normal humans. Diabetes 1986; 5: 563-569.
146. Hevener A, Bergman R, Donovan C. Portal vein afferents are critical for the sympathoadrenal response to hypoglycemia. Diabetes 2000; 1: 8-12.
147. Donovan CM, Halter JB, Bergman RN. Importance of hepatic glucoreceptors in sympathoadrenal response to hypoglycemia. Diabetes 1991; 1: 155-158.
148. Donovan C, Hamiltonwessler M, Halter J, Bergman R. Primacy of liver glucosensors in the sympathetic response to progressive hypoglycemia. Proc Natl Acad Sci USA 1994; 7: 2863-2867.
149. Hamilton-Wessler M, Bergman R, Halter J, Watanabe R, Donovan C. The role of liver glucosensors in the integrated sympathetic response induced by deep hypoglycemia in dogs. Diabetes 1994; 8: 1052-1060.
150. Fujita S, Donovan C. Celiac superior mesenteric ganglionectomy, but not vagotomy, suppresses the sympathoadrenal response to insulin-induced hypoglycemia. Diabetes 2005; 11: 3258-3264.
151. Lamarche L, Yamaguchi N, Peronnet F. Hepatic denervation reduces adrenal catecholamine secretion during insulin-induced hypoglycemia. Am J Physiol Regul Integr Comp Physiol 1995; 1: R50-R57.
152. Donovan CM, Bohland M. Hypoglycemic detection at the portal vein absent in humans or yet to be elucidated? Diabetes 2009; 1: 21-23.
153. Rossetti P, Porcellati F, Lucidi P, Ricci NB, Candeloro P, Cioll P, Santeusanio F, Bolli GB, Fanelli CG. Portal vein glucose sensors do not play a major role in modulating physiological responses to insulin-induced hypoglycemia in humans. Diabetes 2009; 1: 194-202.
154. Ertl AC, Mann S, Richardson A, Briscoe VJ, Blair HB, Tate DB, Davis SN. Effects of oral carbohydrate on autonomic nervous system counterregulatory responses during hyperinsulinemic hypoglycemia and euglycemia. Am J Physiol Endocrinol Metab 2008; 3: E618-E625.
155. Heptulla RA, Tamborlane WV, Ma TYZ, Rife F, Sherwin RS. Oral glucose augments the counterregulatory hormone response during insulin-induced hypoglycemia in humans. J Clin Endocrinol Metab 2001; 2: 645-648.
156. Smith D, Pernet A, Reid H, Bingham E, Rosenthal JM, Macdonald IA, Umpleby AM, Amiel SA. The role of hepatic portal glucose sensing in modulating responses to hypoglycaemia in man. Diabetologia 2002; 10: 1416-1424.
157. Szepietowska B, Zhu W, Chan O, Horblitt A, Dziura J, Sherwin RS. Modulation of beta-adrenergic receptors in the ventromedial hypothalamus influences counterregulatory responses to hypoglycemia. Diabetes 2011; 12: 3154-3158.
158. Ritter S, Bugarith K, Dinh T. Immunotoxic destruction of distinct catecholamine subgroups produces selective impairment of glucoregulatory responses and neuronal activation. J Comp Neurol 2001; 2: 197-216.
159. Borg W, Sherwin R, During M, Borg M, Shulman G. Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release. Diabetes 1995; 2: 180-184.
160. Zhu W, Czyzyk D, Paranjape SA, Zhou L, Horblitt A, Szabo G, Seashore MR, Sherwin RS, Chan O. Glucose prevents the fall in ventromedial hypothalamic GABA that is required for full activation of glucose counterregulatory responses during hypoglycemia. Am J Physiol Endocrinol Metab 2010; 5: E971-E977.
161. Saberi M, Bohland M, Donovan CM. The locus for hypoglycemic rate of fall in glycemia - the role of portal superior mesentieric vein glucose sensing. Diabetes 2008; 5: 1380-1386.
162. Frizzell R, Jones E, Davis S, Biggers D, Myers S, Connolly C, Neal D, Jaspan J, Cherrington A. Counterregulation during hypoglycemia is directed by widespread brain regions. Diabetes 1993; 9: 1253-1261.
163. Biggers D, Myers S, Neal D, Stinson R, Cooper N, Jaspan J, Williams P, Cherrington A, Frizzell R. Role of brain in counterregulation of insulin-induced hypoglycemia in dogs. Diabetes 1989; 1: 7-16.
164. Amiel S, Simonson D, Tamborlane W, Defronzo R, Sherwin R. Rate of glucose fall does not affect counterregulatory hormone responses to hypoglycemia in normal and diabetic humans. Diabetes 1987; 4: 518-522.
165. Defeo P, Gallai V, Mazzotta G, Crispino G, Torlone E, Perriello G, Ventura M, Santeusanio F, Brunetti P, Bolli G. Modest decrements in plasma glucose concentration cause early impairment in cognitive function and later activation of glucose counterregulation in the absence of hypoglycemic symptoms in normal man. J Clin Invest 1988; 2: 436-444.
166. Fanelli C, Pampanelli S, Epifano L, Rambotti A, Ciofetta M, Modarelli F, Divincenzo A, Annibale B, Lepore M, Lalli C, Delsindaco P, Brunetti P, Bolli G. Relative roles of insulin and hypoglycemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycemia in male and female humans. Diabetologia 1994; 8: 797-807.
167. Cryer P. Glucose counterregulation - prevention and correction of hypoglycemia in humans. Am J Physiol 1993; 2: E149-E155.
168. Schwartz N, Clutter W, Shah S, Cryer P. Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. J Clin Invest 1987; 3: 777-781.
169. Mitrakou A, Ryan C, Veneman T, Mokan M, Jenssen T, Kiss I, Durrant J, Cryer P, Gerich J. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol 1991; 1: E67-E74.
170. Vea H, Jorde R, Sager G, Vaaler S, Sundsfjord J. Reproducibility of glycemic thresholds for activation of counterregulatory hormones and hypoglycemic symptoms in healthy subjects. Diabetologia 1992; 10: 958-961.
171. Pardridge WM. Receptor-mediated peptide transport through the blood-brain barrier. Endocr Rev 1986; 3: 314-330.
172. King GL, Johnson SM. Receptor-mediated transport of insulin across endothelial cells. Science 1985; 4694: 1583-1586.
173. Hachiya HL, Halban PA, King GL. Intracellular pathways of insulin transport across vascular endothelial cells. Am J Physiol 1988; 4: C459-C464.
174. Pardridge WM, Eisenberg J, Yang J. Human blood-brain barrier insulin receptor. J Neurochem 1985; 6: 1771-1778.
175. Baura GD, Foster DM, Porte D, Kahn SE, Bergman RN, Cobelli C, Schwartz MW. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo - a mechanism for regulated insulin delivery to the brain. J Clin Invest 1993; 4: 1824-1830.
176. Stein LJ, Dorsa DM, Baskin DG, Figlewicz DP, Ikeda H, Frankmann SP, Greenwood MRC, Porte D, Woods SC. Immunoreactive insulin levels are elevated in the cerebrospinal fluid of genetically obese Zucker rats. Endocrinology 1983; 6: 2299-2301.
177. Strubbe J, Porte D, Woods S. Insulin responses and glucose levels in plasma and cerebrospinal fluid during fasting and refeeding in the rat. Physiol Behav 1988; 2: 205-208.
178. Bilic E, Bilic E, Rudan I, Kusec V, Zurak N, Delimar D, Zagar M. Comparison of the growth hormone, IGF-1 and insulin in cerebrospinal fluid and serum between patients with motor neuron disease and healthy controls. Eur J Neurol 2006; 12: 1340-1345.
179. Bromander S, Anckarsater R, Ahren B, Kristiansson M, Blennow K, Holmang A, Zetterberg H, Anckarsater H, Wass CE. Cerebrospinal fluid insulin during non-neurological surgery. J Neural Transm 2010; 10: 1167-1170.
180. Wallum BJ, Taborsky GJ, Porte D, Figlewicz DP, Jacobson L, Beard JC, Ward WK, Dorsa D. Cerebrospinal fluid insulin levels increase during intravenous insulin infusions in man. J Clin Endocrinol Metab 1987; 1: 190-194.
181. Woods SC, Porte DJ. Relationship between plasma and cerebrospinal fluid insulin levels of dogs. Am J Physiol 1977; 4: E331-E334.
182. Margolis RU, Altszule N. Insulin in cerebrospinal fluid. Nature 1967; 5108: 1375-1376.
183. Plata-Salaman CR. Insulin in the cerebrospinal fluid. Neurosci Biobehav Rev 1991; 2: 243-258.
184. Havrankova J, Schmechel D, Roth J, Brownstein M. Identification of insulin in rat brain. Proc Natl Acad Sci USA 1978; 11: 5737-5741.
185. Havrankova J, Roth J, Brownstein MJ. Concentrations of insulin and of insulin receptors in the brain are independent of peripheral insulin levels - studies of obese and streptozotocin-treated rodents. J Clin Invest 1979; 2: 636-642.
186. Rosenzweig JL, Havrankova J, Lesniak MA, Brownstein M, Roth J. Insulin is ubiquitous in extra-pancreatic tissues of rats and humans. Proc Natl Acad Sci USA 1980; 1: 572-576.
187. Manin M, Mizrahi M, Vye P, Balage M, Grizard J. The influence of acute hyperinsulinemia on the insulin-related material in brain, testis, liver, and kidney. Metabolism 1987; 11: 1067-1072.
188. Schwartz M, Bergman R, Kahn S, Taborsky G, Fisher L, Sipols A, Woods S, Steil G, Porte D. Evidence for entry of plasma insulin into cerebrospinal fluid through an intermediate compartment in dogs - quantitative aspects and implications for transport. J Clin Invest 1991; 4: 1272-1281.
189. Schwartz M, Sipols A, Kahn S, Lattemann D, Taborsky G, Bergman R, Woods S, Porte D. Kinetics and specificity of insulin uptake from plasma into cerebrospinal fluid. Am J Physiol 1990; 3: E378-E383.
190. Wang S, Tulina N, Carlin DL, Rulifson EJ. The origin of islet-like cells in Drosophila identifies parallels to the vertebrate endocrine axis. Proc Natl Acad Sci USA 2007; 50: 19873-19878.
191. Young WS. Periventricular hypothalamic cells in the rat brain contain insulin messenger RNA. Neuropeptides 1986; 2: 93-97.
192. Devaskar SU, Giddings SJ, Rajakumar PA, Carnaghi LR, Menon RK, Zahm DS. Insulin gene expression and insulin synthesis in mammalian neuronal cells. J Biol Chem 1994; 11: 8445-8454.
193. Cooper D, Clarke D. Transcription of the insulin gene in the brain and submandibular gland of the rat. Pediatr Res 1985; 4: A311.
194. Schechter R, Sadiq H, Devaskar S. Insulin and insulin messenger RNA are detected in neuronal cell cultures maintained in an insulin-free serum-free medium. J Histochem Cytochem 1990; 6: 829-836.
195. Schechter R, Holtzclaw L, Sadiq F, Kahn A, Devaskar S. Insulin synthesis by isolated rabbit neurons. Endocrinology 1988; 1: 505-513.
196. Dorn A, Bernstein H, Rinne A, Ziegler M, Hahn H, Ansorge S. Insulinlike and glucagonlike peptides in the brain. Anat Rec 1983; 1: 69-77.
197. Raizada M. Localization of insulin-like immunoreactivity in the neurons from primary cultures of rat brain. Exp Cell Res 1983; 2: 351-357.
198. Oomura Y, Kita H. Insulin acting as a modulator of feeding through the hypothalamus. Diabetologia 1981; 20(Suppl.): 290-298.
199. Coker G, Studelska D, Harmon S, Burke W, Omalley K. Analysis of tyrosine hydroxylase and insulin transcripts in human neuroendocrine tissues. Mol Brain Res 1990; 2: 93-98.
200. Giddings S, Chirgwin J, Permutt M. Evaluation of rat insulin messenger RNA in pancreatic and extrapancreatic tissues. Diabetologia 1985; 6: 343-347.
201. Adamo M, Raizada M, Leroith D. Insulin and insulin-like growth-factor receptors in the nervous system. Mol Neurobiol 1989; 1-2: 71-100.
202. Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte D. Insulin in the brain - a hormonal regulator of energy balance. Endocr Rev 1992; 3: 387-414.
203. Baskin D, Woods S, West D, Vanhouten M, Posner B, Dorsa D, Porte D. Immunocytochemical detection of insulin in rat hypothalamus and its possible uptake from cerebrospinal fluid. Endocrinology 1983; 5: 1818-1825.
204. Havrankova J, Roth J. Insulin receptors are widely distributed in central nervous system of rat. Nature 1978; 5656: 827-829.
205. Hill J, Lesniak M, Pert C, Roth J. Autoradiographic localization of insulin receptors in rat brain - prominence in olfactory and limbic areas. Neuroscience 1986; 4: 1127-1138.
206. Lowe W, Boyd F, Clarke D, Raizada M, Hart C, Leroith D. Development of brain insulin receptors - structural and functional studies of insulin receptors from whole brain and primary cell cultures. Endocrinology 1986; 1: 25-35.
207. Unger J, McNeill T, Moxley R, White M, Moss A, Livingston J. Distribution of insulin receptor-like immunoreactivity in the rat forebrain. Neuroscience 1989; 1: 143-157.
208. Zhu S, Kum W, Ho S, Young J, Cockram C. Structure-function relationships of insulin receptor interactions in cultured mouse astrocytes. Brain Res 1990; 12: 329-332.
209. Unger J, Moss A, Livingston J. Immunohistochemical localization of insulin receptors and phosphotyrosine in the brain-stem of the adult rat. Neuroscience 1991; 3: 853-861.
210. Hendricks S, Agardh C, Taylor S, Roth J. Unique features of the insulin receptor in rat brain. J Neurochem 1984; 5: 1302-1309.
211. Heidenreich K, Zahniser N, Berhanu P, Brandenburg D, Olefsky J. Structural differences between insulin receptors in the brain and peripheral target tissues. J Biol Chem 1983; 14: 8527-8530.
212. Heidenreich K, Brandenburg D. Oligosaccharide heterogeneity of insulin receptors - comparison of n-linked glycosylation of insulin receptors in adipocytes and brain. Endocrinology 1986; 5: 1835-1842.
213. Ciaraldi T, Robbins R, Leidy J, Thamm P, Berhanu P. Insulin receptors on cultured hypothalamic cells - functional and structural differences from receptors on peripheral target cells. Endocrinology 1985; 6: 2179-2185.
214. Gammeltoft S, Staunolsen P, Ottesen B, Fahrenkrug J. Insulin receptors in rat brain cortex - kinetic evidence for a receptor subtype in the central nervous system. Peptides 1984; 5: 937-944.
215. Zahniser N, Goens M, Hanaway P, Vinych J. Characterization and regulation of insulin receptors in rat brain. J Neurochem 1984; 5: 1354-1362.
216. Kobayashi M, Olefsky J. Effect of experimental hyperinsulinemia on insulin binding and glucose transport in isolated rat adipocytes. Am J Physiol 1978; 1: E53-E62.
217. Blackard W, Guzelian P, Small M. Down regulation of insulin receptors in primary cultures of adult rat hepatocytes in monolayer. Endocrinology 1978; 2: 548-553.
218. Rohilla A, Anderson C, Wood W, Berhanu P. Insulin down-regulates the steady-state level of its receptors messenger ribonucleic acid. Biochem Biophys Res Commun 1991; 2: 520-526.
219. Manin M, Balage M, Larueachagiotis C, Grizard J. Chronic intracerebroventricular infusion of insulin failed to alter brain insulin-binding sites, food intake, and body weight. J Neurochem 1988; 6: 1689-1695.
220. Melnyk R, Martin J. Failure of chronic experimental hyperinsulinism to alter insulin binding to hypothalamic receptors in the rat. Acta Endocrinol 1984; 1: 86-90.
221. Marfaing P, Penicaud L, Broer Y, Mraovitch S, Calando Y, Picon L. Effects of hyperinsulinemia on local cerebral insulin binding and glucose utilization in normoglycemic awake rats. Neurosci Lett 1990; 2-3: 279-285.
222. Saltiel AR, Pessin JE. Insulin signaling pathways in time and space. Trends Cell Biol 2002; 2: 65-71.
223. Brant AM, Jess TJ, Milligan G, Brown CM, Gould GW. Immunological analysis of glucose transporters expressed in different regions of the rat brain and central nervous system. Biochem Biophys Res Commun 1993; 3: 1297-1302.
224. Vannucci S, Koehler-Stec E, Li K, Reynolds T, Clark R, Simpson I. GLUT4 glucose transporter expression in rodent brain: effect of diabetes. Brain Res 1998; 1: 1-11.
225. Ibberson M, Uldry M, Thorens B. GLUTX1, a novel mammalian glucose transporter expressed in the central nervous system and insulin-sensitive tissues. J Biol Chem 2000; 7: 4607-4612.
226. Reagan L, Gorovits N, Hoskin E, Alves S, Katz E, Grillo C, Piroli G, McEwen B, Charron M. Localization and regulation of GLUTx1 glucose transporter in the hippocampus of streptozotocin diabetic rats. Proc Natl Acad Sci USA 2001; 5: 2820-2825.
227. Piroli G, Grillo C, Hoskin E, Znamensky V, Katz E, Milner T, McEwen B, Charron M, Reagan L. Peripheral glucose administration stimulates the translocation of GLUT8 glucose transporter to the endoplasmic reticulum in the rat hippocampus. J Comp Neurol 2002; 2: 103-114.
228. Shin B, McKnight R, Devaskar S. Glucose transporter GLUT8 translocation in neurons is not insulin responsive. J Neurosci Res 2004; 6: 835-844.
229. Leino R, Gerhart D, van Bueren A, McCall A, Drewes L. Ultrastructural localization of GLUT 1 and GLUT 3 glucose transporters in rat brain. J Neurosci Res 1997; 5: 617-626.
230. Uemura E, Greenlee H. Amyloid beta-peptide inhibits neuronal glucose uptake by preventing exocytosis. Exp Neurol 2001; 2: 270-276.
231. Uemura E, Greenlee H. Insulin regulates neuronal glucose uptake by promoting translocation of glucose transporter GLUT3. Exp Neurol 2006; 1: 48-53.
232. Castaneda-Sceppa C, Castaneda F. Sodium-dependent glucose transporter protein as a potential therapeutic target for improving glycemic control in diabetes. Nutr Rev 2011; 12: 720-729.
233. +/glucose cotransporters. J Exp Biol 1997; 2: 287-293.
234. +/glucose cotransporter expression by protein kinases in Xenopus laevis oocytes. J Biol Chem 1996; 25: 14740-14746.
235. Stumpel F, Kucera T, Gardemann A, Jungermann K. Acute increase by portal insulin in intestinal glucose absorption via hepatoenteral nerves in the rat. Gastroenterology 1996; 6: 1863-1869.
236. Westergaard H. Insulin modulates rat intestinal glucose transport - effect of hypoinsulinemia and hyperinsulinemia. Am J Physiol 1989; 5: G911-G918.
237. + ATPase in enterocytes but increases intestinal glucose absorption. Gen Comp Endocrinol 2010; 2: 228-233.
238. Barnea M, Madar Z, Froy O. Glucose and insulin are needed for optimal defensin expression in human cell lines. Biochem Biophys Res Commun 2008; 2: 452-456.
239. Strubbe J, Steffens A. Rapid insulin release after ingestion of a meal in unanesthetized rat. Am J Physiol 1975; 4: 1019-1022.
240. Steffens A. Influence of oral cavity on insulin release in rat. Am J Physiol 1976; 5: 1411-1415.
241. Berthoud H, Trimble E, Siegel E, Bereiter D, Jeanrenaud B. Cephalic-phase insulin-secretion in normal and pancreatic islet-transplanted rats. Am J Physiol 1980; 4: E336-E340.
242. Bruce D, Storlien L, Furler S, Chisholm D. Cephalic phase metabolic responses in normal weight adults. Metabolism 1987; 8: 721-725.
243. Berthoud H, Bereiter D, Trimble E, Siegel E, Jeanrenaud B. Cephalic phase, reflex insulin secretion - neuroanatomical and physiological characterization. Diabetologia 1981; 20(Suppl.): 393-401.
244. Ahren B. Autonomic regulation of islet hormone secretion - implications for health and disease. Diabetologia 2000; 4: 393-410.
245. Berthoud H, Powley T. Identification of vagal preganglionics that mediate cephalic phase insulin response. Am J Physiol 1990; 2: R523-R530.
246. Teff K, Levin B, Engelman K. Oral sensory stimulation in men - effects on insulin, c-peptide, and catecholamines. Am J Physiol 1993; 6: R1223-R1230.
247. Simon C, Schlienger J, Sapin R, Imler M. Cephalic phase insulin secretion in relation to food presentation in normal and overweight subjects. Physiol Behav 1986; 3: 465-469.
248. Teff K, Mattes R, Engelman K. Cephalic phase insulin release in normal weight males - verification and reliability. Am J Physiol 1991; 4: E430-E436.
249. Sahakian B, Lean M, Robbins T, James W. Salivation and insulin-secretion in response to food in nonobese men and women. Appetite 1981; 3: 209-216.
250. Teff K, Mattes R, Engelman K, Mattern J. Cephalic-phase insulin in obese and normal-weight men - relation to postprandial insulin. Metabolism 1993; 12: 1600-1608.
251. Teff K, Engelman K. Oral sensory stimulation improves glucose tolerance in humans: effects on insulin, C-peptide, and glucagon. Am J Physiol Regul Integr Comp Physiol 1996; 6: R1371-R1379.
252. Callesescandon J, Robbins D. Loss of early phase of insulin release in humans impairs glucose tolerance and blunts thermal effect of glucose. Diabetes 1987; 10: 1167-1172.
253. Del Prato S, Miccoli R, Penno G. Review: the importance of effective early phase insulin secretion. Br J Diabetes Vasc Dis 2005; 4: 198-202.
254. Weyer C, Tataranni P, Bogardus C, Pratley R. Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type a diabetes development. Diabetes Care 2001; 1: 89-94.
255. Ward W, Bolgiano D, McKnight B, Halter J, Porte D. Diminished B-cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Invest 1984; 4: 1318-1328.
256. Perley M, Kipnis D. Plasma insulin responses to oral and intravenous glucose - studies in normal and diabetic subjects. J Clin Invest 1967; 12: 1954-1962.
257. Ahima RS, Antwi DA. Brain regulation of appetite and satiety. Endocrinol Metab Clin North Am 2008; 4: 811-823.
258. Brown LM, Clegg DJ, Benoit SC, Woods SC. Intraventricular insulin and leptin reduce food intake and body weight in C57BL/6J mice. Physiol Behav 2006; 5: 687-691.
259. Air E, Benoit S, Smith K, Clegg D, Woods S. Acute third ventricular administration of insulin decreases food intake in two paradigms. Pharmacol Biochem Behav 2002; 1-2: 423-429.
260. Bruijnzeel AW, Corrie LW, Rogers JA, Yamada H. Effects of insulin and leptin in the ventral tegmental area and arcuate hypothalamic nucleus on food intake and brain reward function in female rats. Behav Brain Res 2011; 2: 254-264.
261. McGowan M, Andrews K, Grossman S. Chronic intrahypothalamic infusions of insulin or insulin antibodies alter body weight and food intake in the rat. Physiol Behav 1992; 4: 753-766.
262. Ikeda H, West D, Pustek J, Figlewicz D, Greenwood M, Porte D, Woods S. Intraventricular insulin reduces food intake and body weight of lean but not obese Zucker rats. Appetite 1986; 4: 381-386.
263. Woods S, Lotter E, McKay L, Porte D. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature 1979; 5738: 503-505.
264. Strubbe J, Mein C. Increased feeding in response to bilateral injection of insulin antibodies in VMH. Physiol Behav 1977; 2: 309-313.
265. Vanderweele D, Haraczkiewicz E, Vanitallie T. Elevated insulin and satiety in obese and normal-weight rats. Appetite 1982; 2: 99-109.
266. Woods S, Stein L, McKay L, Porte D. Suppression of food intake by intravenous nutrients and insulin in the baboon. Am J Physiol 1984; 2: R393-R401.
267. Bruning J, Gautam D, Burks D, Gillette J, Schubert M, Orban P, Klein R, Krone W, Muller-Wieland D, Kahn C. Role of brain insulin receptor in control of body weight and reproduction. Science 2000; 5487: 2122-2125.
268. Clegg D, Benoit S, Reed J, Woods S, Dunn-Meynell A, Levin B. Reduced anorexic effects of insulin in obesity-prone rats fed a moderate-fat diet. Am J Physiol Regul Integr Comp Physiol 2005; 4: R981-R986.
269. Kappy M, Sellinger S, Raizada M. Insulin binding in 4 regions of the developing rat brain. J Neurochem 1984; 1: 198-203.
270. Marks J, Eastman C. Ontogeny of insulin binding in different regions of the rat brain. Dev Neurosci 1990; 6: 349-358.
271. Baronvanevercooren A, Olichonberthe C, Kowalski A, Visciano G, Vanobberghen E. Expression of IGF-I and insulin receptor genes in the rat central nervous system - a developmental, regional, and cellular analysis. J Neurosci Res 1991; 2: 244-253.
272. Sankar R, Thamotharan S, Shin D, Moley K, Devaskar S. Insulin-responsive glucose transporters - GLUT8 and GLUT4 are expressed in the developing mammalian brain. Mol Brain Res 2002; 2: 157-165.
273. Bhat N. Insulin dependent neurite outgrowth in cultured embryonic mouse brain cells. Dev Brain Res 1983; 2: 315-318.
274. Vanhems E, Delbos M, GirardieI J. Insulin and neuroparsin promote neurite outgrowth in cultured locust CNS. Eur J Neurosci 1990; 9: 776-782.
275. Russell D, Snyder S. Amine synthesis in rapidly growing tissues - ornithine decarboxylase activity in regenerating rat liver chick embryo and various tumors. Proc Natl Acad Sci USA 1968; 4: 1420-1427.
276. Yang J, Raizada M, Fellows R. Effects of insulin on cultured rat-brain cells - stimulation of ornithine decarboxylase activity. J Neurochem 1981; 3: 1050-1057.
277. Hansson A, Ingelmansundberg M. Insulin-stimulated protein-synthesis in adipocytes - enhanced rate of initiation associated with increased phosphorylation of ribosomal protein-S6. Eur J Biochem 1985; 1: 97-100.
278. Heidenreich K, Toledo S. Insulin receptors mediate growth effects in cultured fetal neurons. 2. Activation of a protein kinase that phosphorylates ribosomal protein S6. Endocrinology 1989; 3: 1458-1463.
279. Auer R. Hypoglycemic brain damage. Forensic Sci Int 2004; 2-3: 105-110.
280. Bjorgaas MR. Cerebral effects of severe hypoglycemia in young people with type 1 diabetes. Pediatr Diabetes 2012; 1: 100-107.
281. Feise G, Kogure K, Busto R, Scheinberg P, Reinmuth O. Effect of insulin hypoglycemia upon cerebral energy metabolism and EEG activity in rat. Brain Res 1977; 2: 263-280.
282. Sommerfield A, Deary I, McAulay V, Frier B. Short-term, delayed, and working memory are impaired during hypoglycemia in individuals with type 1 diabetes. Diabetes Care 2003; 2: 390-396.
283. Pramming S, Thorsteinsson B, Stigsby B, Binder C. Glycemic threshold for changes in electroencephalograms during hypoglycemia in patients with insulin dependent diabetes. Br Med J 1988; 6623: 665-667.
284. Tribl G, Howorka K, Heger G, Anderer P, Thoma H, Zeitlhofer J. EEG topography during insulin-induced hypoglycemia in patients with insulin-dependent diabetes mellitus. Eur Neurol 1996; 5: 303-309.
285. Stigsby B, Pramming S, Thorsteinsson B. Insulin induced hypoglycemia - EEG changes in diabetics. Electroencephalogr Clin Neurophysiol 1985; 3: S172.
286. Auer R, Olsson Y, Siesjo B. Hypoglycemic brain injury in the rat - correlation of density of brain damage with the EEG isoelectric time - a quantitative study. Diabetes 1984; 11: 1090-1098.
287. Auer R, Wieloch T, Olsson Y, Siesjo B. The distribution of hypoglycemic brain damage. Acta Neuropathol 1984; 3: 177-191.
288. Suh SW, Hamby AM, Swanson RA. Hypoglycemia, brain energetics, and hypoglycemic neuronal death. Glia 2007; 12: 1280-1286.
289. Tasker R, Coyle J, Vornov J. The regional vulnerability to hypoglycemia-induced neurotoxicity in organotypic hippocampal culture - protection by early tetrodotoxin or delayed Mk-801. J Neurosci 1992; 11: 4298-4308.
290. Auer R, Kalimo H, Olsson Y, Wieloch T. The dentate gyrus in hypoglycemia - pathology implicating excitotoxin-mediated neuronal necrosis. Acta Neuropathol 1985; 3-4: 279-288.
291. Auer R, Siesjo B. Biological differences between ischemia, hypoglycemia, and epilepsy. Ann Neurol 1988; 6: 699-707.
292. Auer R, Kalimo H, Olsson Y, Siesjo B. The temporal evolution of hypoglycemic brain-damage. 2. Light-microscopic and electron-microscopic findings in the hippocampal gyrus and subiculum of the rat. Acta Neuropathol 1985; 1-2: 25-36.
293. Wieloch T. Hypoglycemia-induced neuronal damage prevented by an N-methyl-d-aspartate antagonist. Science 1985; 4726: 681-683.
294. Jansen K, Dragunow M, Faull R. [H-3] Glycine binding sites, NMDA and PCP receptors have similar distributions in the human hippocampus - an autoradiographic study. Brain Res 1989; 1: 174-178.
295. Sandberg M, Butcher S, Hagberg H. Extracellular overflow of neuroactive amino acids during severe insulin-induced hypoglycemia - in vivo dialysis of the rat hippocampus. J Neurochem 1986; 1: 178-184.
296. Shin BS, Won SJ, Yoo BH, Kauppinen TM, Suh SW. Prevention of hypoglycemia-induced neuronal death by hypothermia. J Cereb Blood Flow Metab 2010; 2: 390-402.
297. Suh S, Garnier P, Aoyama K, Chen Y, Swanson R. Zinc release contributes to hypoglycemia-induced neuronal death. Neurobiol Dis 2004; 3: 538-545.
298. Suh SW, Gum ET, Hamby AM, Chan PH, Swanson RA. Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. J Clin Invest 2007; 4: 910-918.
299. Frederickson C, Rampy B, Reamy-Rampy S, Howell G. Distribution of histochemically reactive zinc in the forebrain of the rat. J Chem Neuroanat 1992; 6: 521-530.
300. Won SJ, Kim JH, Yoo BH, Sohn M, Kauppinen TM, Park M, Kwon H, Liu J, Suh SW. Prevention of hypoglycemia-induced neuronal death by minocycline. J Neuroinflammation 2012; 9: 225-236.
301. Singh P, Jain A, Kaur G. Impact of hypoglycemia and diabetes on CNS: correlation of mitochondrial oxidative stress with DNA damage. Mol Cell Biochem 2004; 1-2: 153-159.
302. Haces ML, Montiel T, Massieu L. Selective vulnerability of brain regions to oxidative stress in a non-coma model of insulin-induced hypoglycemia. Neuroscience 2010; 1: 28-38.
303. Patockova J, Marhol P, Tumova E, Krsiak M, Rokyta R, Stipek S, Crkovska J, Andel M. Oxidative stress in the brain tissue of laboratory mice with acute post insulin hypoglycemia. Physiol Res 2003; 1: 131-135.
304. Dawson T, Dawson V, Snyder S. A novel neuronal messenger molecule in brain - the free radical, nitric oxide. Ann Neurol 1992; 3: 297-311.
305. Hassoun E, Vodhanel J, Holden B, Abushaban A. The effects of ellagic acid and vitamin E succinate on antioxidant enzymes activities and glutathione levels in different brain regions of rats after subchronic exposure to TCDD. J Toxicol Environ Health A 2006; 5: 381-393.
306. Didier M, Bursztajn S, Adamec E, Passani L, Nixon R, Coyle J, Wei J, Berman S. DNA strand breaks induced by sustained glutamate excitotoxicity in primary neuronal cultures. J Neurosci 1996; 7: 2238-2250.
307. Ennis K, Tran PV, Seaquist ER, Rao R. Postnatal age influences hypoglycemia-induced neuronal injury in the rat brain. Brain Res 2008; 1124: 119-126.
308. Duvanel C, Fawer C, Cotting J, Hohlfeld P, Matthieu J. Long-term effects of neonatal hypoglycemia on brain growth and psychomotor development in small-for-gestational-age preterm infants. J Pediatr 1999; 4: 492-498.
309. Lucas A, Morley R, Cole T. Adverse neurodevelopmental outcome of moderate neonatal hypoglycemia. Br Med J 1988; 6659: 1304-1308.
310. Anderson J, Milner R, Strich S. Effects of neonatal hypoglycaemia on nervous system - a pathological study. J Neurol Neurosurg Psychiatry 1967; 4: 295-310.
311. Montassir H, Maegaki Y, Ogura K, Kurozawa Y, Nagata I, Kanzaki S, Ohno K. Associated factors in neonatal hypoglycemic brain injury. Brain Dev 2009; 9: 649-656.
312. Taborsky G, Ahren B, Havel P. Autonomic mediation of glucagon secretion during hypoglycemia - implications for impaired alpha-cell responses in type 1 diabetes. Diabetes 1998; 7: 995-1005.
313. Taborsky GJ Jr, Mundinger TO. Minireview: the role of the autonomic nervous system in mediating the glucagon response to hypoglycemia. Endocrinology 2012; 3: 1055-1062.
314. Rizza RA, Cryer PE, Haymond MW, Gerich JE. Adrenergic-mechanisms for the effects of epinephrine on glucose production and clearance in man. J Clin Invest 1980; 3: 682-689.
315. Rizza R, Haymond M, Cryer P, Gerich J. Differential effects of epinephrine on glucose production and disposal in man. Am J Physiol 1979; 4: E356-E362.
316. Exton J, Robinson G, Sutherla E, Park C. Studies on role of adenosine 3', 5'-monophosphate in hepatic actions of glucagon and catecholamines. J Biol Chem 1971; 20: 6166-6177.
317. Lefebvre P. Glucagon and adipose tissue. Biochem Pharmacol 1975; 13: 1261-1266.
318. Moller N, Jorgensen JOL. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev 2009; 2: 152-177.
319. Fineberg SE, Merimee TJ. Acute metabolic effects of human growth hormone. Diabetes 1974; 6: 499-504.
320. Munck A. Glucocorticoid inhibition of glucose uptake by peripheral tissues - old and new evidence, molecular mechanisms, and physiological significance. Perspect Biol Med 1971; 2: 265-269.
321. Hu Y, Wilson G. Rapid changes in local extracellular rat brain glucose observed with an in vivo glucose sensor. J Neurochem 1997; 4: 1745-1752.
322. Maher F, DaviesHill T, Simpson I. Substrate specificity and kinetic parameters of GLUT3 in rat cerebellar granule neurons. Biochem J 1996; 3: 827-831.
323. Colville C, Seatter M, Jess T, Gould G, Thomas H. Kinetic analysis of the liver type (GLUT2) and brain-type (GLUT3) glucose transporters in Xenopus oocytes - substrate specificities and effects of transport inhibitors. Biochem J 1993; 3: 701-706.
324. Maher F, Vannucci S, Simpson I. Glucose transporter isoforms in brain - absence of GLUT3 from the blood-brain barrier. J Cereb Blood Flow Metab 1993; 2: 342-345.
325. Maher F, Vannucci S, Simpson I. Glucose transporter proteins in brain. FASEB J 1994; 13: 1003-1011.
326. Maher F, Simpson I. The GLUT3 glucose transporter is the predominant isoform in primary cultured neurons - assessment by biosynthetic and photoaffinity-labeling. Biochem J 1994; 2: 379-384.
327. Nishimura H, Pallardo F, Seidner G, Vannucci S, Simpson I, Birnbaum M. Kinetics of GLUT1 and GLUT4 glucose transporters expressed in Xenopus oocytes. J Biol Chem 1993; 12: 8514-8520.
328. Rumsey S, Daruwala R, Al-Hasani H, Zarnowski M, Simpson I, Levine M. Dehydroascorbic acid transport by GLUT4 in Xenopus oocytes and isolated rat adipocytes. J Biol Chem 2000; 36: 28246-28253.
329. Ibberson M, Riederer B, Uldry M, Guhl B, Roth J, Thorens B. Immunolocalization of GLUTX1 in the testis and to specific brain areas and vasopressin-containing neurons. Endocrinology 2002; 1: 276-284.
330. +-d-glucose cotransporter in muscle capillaries increases glucose permeability. Biochem Biophys Res Commun 2004; 2: 301-305.
331. +/glucose cotransporter. J Biol Chem 2001; 52: 49188-49194.
332. Loo DDF, Hirayama BA, Sala-Rabanal M, Wright EM. How drugs interact with transporters: SGLT1 as a model. J Membr Biol 2008; 2: 87-106.
333. +-glucose cotransporters (SGLT-1). Am J Physiol Gastrointest Liver Physiol 1996; 6: G919-G926.
334. +-glucose cotransporter in Xenopus laevis oocytes. J Physiol (Lond) 1999; 2: 359-371.
335. +-dependent glucose cotransporter hSGLT2. Am J Physiol Cell Physiol 2012; 3: C348-C354.
336. Arluison M, Quignon M, Thorens B, Leloup C, Penicaud L. Immunocytochemical localization of the glucose transporter 2 (GLUT2) in the adult rat brain. II. Electron microscopic study. J Chem Neuroanat 2004; 3: 137-146.
337. Farrell C, Pardridge W. Blood-brain barrier glucose transporter is asymmetrically distributed on brain capillary endothelial lumenal and ablumenal membranes - an electron microscopic immunogold study. Proc Natl Acad Sci USA 1991; 13: 5779-5783.
338. McNay EC, Gold PE. Extracellular glucose concentrations in the rat hippocampus measured by zero-net-flux: effects of microdialysis flow rate, strain, and age. J Neurochem 1999; 2: 785-790.
339. Reinstrup P, Stahl N, Mellergard P, Uski T, Ungerstedt U, Nordstrom C. Intracerebral microdialysis in clinical practice: baseline values for chemical markers during wakefulness, anesthesia, and neurosurgery. Neurosurgery 2000; 3: 701-709.
340. Mastaitis J, Wurmbach E, Cheng H, Sealfon S, Mobbs C. Acute induction of gene expression in brain and liver by insulin-induced hypoglycemia. Diabetes 2005; 4: 952-958.